Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price objective hoisted by HSBC from $660.00 to $670.00 in a report released on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the medical research company’s stock. HSBC’s price target indicates a potential upside of 17.12% from the company’s current price. Several […] Read this story
